|
Horwitz, Lawrence D; Horwitz, Marcus A (2014) The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses. Antioxid Redox Signal 21:2246-61
|
|
Ambler, S Kelly; Hodges, Yvonne K; Jones, Gayle M et al. (2008) Prolonged administration of a dithiol antioxidant protects against ventricular remodeling due to ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 295:H1303-H1310
|
|
Pahl, Paula M B; Reese, Sara M; Horwitz, Lawrence D (2007) A lipid-soluble iron chelator alters cell cycle regulatory protein binding in breast cancer cells compared to normal breast cells. J Exp Ther Oncol 6:193-200
|
|
Hodges, Yvonne K; Weinberger, Howard D; Stephens, Janet et al. (2006) Desferri-Exochelin, a lipid-soluble, hexadentate iron chelator, effectively removes tissue iron. Transl Res 148:63-71
|
|
Hodges, Yvonne K; Reese, Sara M; Pahl, Paula M B et al. (2005) Paradoxical effects of iron chelation on growth of vascular endothelial cells. J Cardiovasc Pharmacol 45:539-44
|
|
Pahl, Paula M B; Horwitz, Lawrence D (2005) Cell permeable iron chelators as potential cancer chemotherapeutic agents. Cancer Invest 23:683-91
|
|
Hodges, Yvonne K; Antholine, William E; Horwitz, Lawrence D (2004) Effect on ribonucleotide reductase of novel lipophilic iron chelators: the desferri-exochelins. Biochem Biophys Res Commun 315:595-8
|
|
Horwitz, L D; Sherman, N A (2001) Bucillamine prevents myocardial reperfusion injury. J Cardiovasc Pharmacol 38:859-67
|
|
Pahl, P M; Horwitz, M A; Horwitz, K B et al. (2001) Desferri-exochelin induces death by apoptosis in human breast cancer cells but does not kill normal breast cells. Breast Cancer Res Treat 69:69-79
|
|
Rosenthal, E A; Bohlmeyer, T J; Monnet, E et al. (2001) An iron-binding exochelin prevents restenosis due to coronary artery balloon injury in a porcine model. Circulation 104:2222-7
|
Showing the most recent 10 out of 17 publications
